|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date03 May 1951 |
依酚氯铵注射液用于拮抗罗库溴铵注射液残留神经肌肉阻滞的安全性、药动学及有效性临床研究
[Translation] Clinical study on the safety, pharmacokinetics and efficacy of edrocuronium injection in antagonizing residual neuromuscular blockade caused by rocuronium injection
主要目的:研究依酚氯铵注射液在全身麻醉手术后患者中与硫酸阿托品注射液同时单次静脉注射给药的药代动力学特征,并与国外文献数据进行对比分析,为借鉴原研产品说明书的用法用量提供药代动力学依据。次要目的:评估依酚氯铵注射液的安全性;初步评估依酚氯铵注射液拮抗残留神经肌肉阻滞的疗效。
[Translation] The main purpose is to study the pharmacokinetic characteristics of edrophonium injection administered as a single intravenous injection in patients undergoing general anesthesia surgery and to compare and analyze the data from foreign literature to provide a pharmacokinetic basis for the use and dosage of the original product instructions. The secondary purpose is to evaluate the safety of edrophonium injection and preliminarily evaluate the efficacy of edrophonium injection in antagonizing residual neuromuscular blockade.
100 Clinical Results associated with Jinan Boshi Medical Technology Co., Ltd.
0 Patents (Medical) associated with Jinan Boshi Medical Technology Co., Ltd.
100 Deals associated with Jinan Boshi Medical Technology Co., Ltd.
100 Translational Medicine associated with Jinan Boshi Medical Technology Co., Ltd.